OnDemand WTP Pricing Research

Straumann sales rise as pricing strategy takes hold | Pinfex

Straumann Holding AG, the world’s largest maker of dental implants, posted a 2.9 percent rise in sales in the first quarter as it started to reap the benefit of a new pricing strategy. The premium dental implant market has shown tentative signs of a turnaround in recent quarters, after the financial crisis made consumers in developed countries postpone or scrap non-urgent treatment and trade down to cheaper brands. Basel, Switzerland-based Straumann is encouraging customers to trade up to its premium Roxolid implants by offering the newer product at the same price as an older range, in a bid to close the gap on rivals and win market share. The strategy may be paying off, with revenue up 4 percent in its biggest market Europe in the first quarter compared with a 7.5 percent fall a year earlier.

Read complete article here:

Straumann sales rise as pricing strategy takes hold.